Table IV.
Correlation coefficients between osteoporosis pharmacological treatment and osteoporosis-related biomarkers (r = correlation coefficient, n = 398).
| Biomarker | Medication | Overall (n = 398) | ||||
|---|---|---|---|---|---|---|
| Yes (n = 88) | No (n = 310) | |||||
| r | p-value | r | p-value | r | p-value | |
| TRACP-5b | -0.029 | 0.789 | -0.261 | < 0.001 | -0.197 | < 0.001 |
| Total P1NP | -0.033 | 0.763 | -0.189 | < 0.001 | -0.121 | 0.016 |
| Intact PTH | 0.047 | 0.662 | -0.061 | 0.284 | 0.284 | 0.514 |
| Homocysteine | 0.205 | 0.056 | 0.017 | 0.761 | 0.032 | 0.530 |
Medication: whether patients are using osteoporosis medication.
P1NP, procollagen type 1 amino-terminal propeptide; PTH, parathyroid hormone; TRACP-5b, tartrate-resistant acid phosphatase 5b.